Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTSG BrightSpring Health Services	$19.94 -0.8%	$22.50	$10.15 ▼ $25.57	$3.51B	2.3	1.67 million shs	1.14 million shs
OPCH Option Care Health	$29.48 -1.5%	$31.58	$21.39 ▼ $35.53	$4.83B	0.73	1.83 million shs	954,581 shs
RDNT RadNet	$57.49 -2.3%	$57.29	$45.00 ▼ $93.65	$4.31B	1.41	689,569 shs	1.35 million shs
VRDN Viridian Therapeutics	$16.52 -3.1%	$14.80	$9.90 ▼ $27.20	$1.35B	0.39	1.14 million shs	511,541 shs

10 Stocks Set to Soar in Summer 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTSG BrightSpring Health Services	0.00%	-1.82%	-10.46%	+27.66%	+70.43%
OPCH Option Care Health	0.00%	-1.34%	-6.50%	-5.66%	-2.80%
RDNT RadNet	0.00%	+3.62%	+4.09%	+21.39%	-7.27%
VRDN Viridian Therapeutics	0.00%	-3.05%	+12.23%	+25.82%	+14.17%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BTSG BrightSpring Health Services	1.9537 of 5 stars	2.5	1.0	0.0	3.3	0.8	1.9
OPCH Option Care Health	4.5033 of 5 stars	2.4	5.0	4.3	3.1	1.7	1.9
RDNT RadNet	3.7142 of 5 stars	2.8	2.0	4.6	2.7	2.5	0.0
VRDN Viridian Therapeutics	3.2362 of 5 stars	4.5	5.0	0.0	2.3	0.0	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTSG BrightSpring Health Services	2.91	Moderate Buy	$24.90	24.87% Upside
OPCH Option Care Health	2.88	Moderate Buy	$35.50	20.42% Upside
RDNT RadNet	3.50	Strong Buy	$69.60	21.06% Upside
VRDN Viridian Therapeutics	2.90	Moderate Buy	$37.56	127.33% Upside

Current Analyst Ratings Breakdown

Latest VRDN, OPCH, RDNT, and BTSG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/10/2025	RDNT RadNet	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$74.00
7/10/2025	OPCH Option Care Health	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$38.00
6/23/2025	BTSG BrightSpring Health Services	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00
6/18/2025	OPCH Option Care Health	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$36.00
6/13/2025	RDNT RadNet	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$69.00
6/12/2025	RDNT RadNet	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Buy ➝ Strong-Buy
5/20/2025	VRDN Viridian Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$36.00 ➝ $36.00
5/13/2025	BTSG BrightSpring Health Services	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$25.00 ➝ $27.00
5/9/2025	BTSG BrightSpring Health Services	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$20.00 ➝ $25.00
5/7/2025	VRDN Viridian Therapeutics	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$31.00 ➝ $27.00
5/7/2025	VRDN Viridian Therapeutics	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$46.00 ➝ $45.00

(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTSG BrightSpring Health Services	$11.27B	0.31	$1.87 per share	10.66	$9.46 per share	2.11
OPCH Option Care Health	$5.00B	0.97	$1.65 per share	17.92	$8.25 per share	3.57
RDNT RadNet	$1.83B	2.36	$3.48 per share	16.50	$15.31 per share	3.76
VRDN Viridian Therapeutics	$300K	4,492.89	N/A	N/A	$6.09 per share	2.71

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTSG BrightSpring Health Services	-$18.06M	$0.28	71.21	24.32	N/A	0.49%	7.76%	2.20%	8/1/2025 (Estimated)
OPCH Option Care Health	$211.82M	$1.24	23.77	23.40	1.78	4.12%	16.90%	7.00%	7/30/2025 (Estimated)
RDNT RadNet	$2.79M	-$0.43	N/A	108.47	N/A	-1.73%	1.41%	0.48%	8/6/2025 (Estimated)
VRDN Viridian Therapeutics	-$269.95M	-$3.85	N/A	N/A	N/A	-102,092.39%	-70.61%	-44.67%	8/14/2025 (Estimated)

Latest VRDN, OPCH, RDNT, and BTSG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	VRDN Viridian Therapeutics	-$1.01	N/A	N/A	N/A	N/A	N/A
8/6/2025	Q2 2025	RDNT RadNet	$0.17	N/A	N/A	N/A	$488.06 million	N/A
8/1/2025	Q2 2025	BTSG BrightSpring Health Services	$0.22	N/A	N/A	N/A	$2.99 billion	N/A
7/30/2025	Q2 2025	OPCH Option Care Health	$0.40	N/A	N/A	N/A	$1.35 billion	N/A
5/6/2025	Q1 2025	VRDN Viridian Therapeutics	-$0.95	-$0.87	+$0.08	-$0.87	$0.16 million	$0.07 million
5/2/2025	Q1 2025	BTSG BrightSpring Health Services	$0.09	$0.19	+$0.10	$0.14	$2.74 billion	$2.88 billion
4/29/2025	Q1 2025	OPCH Option Care Health	$0.36	$0.40	+$0.04	$0.28	$1.26 billion	$1.33 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTSG BrightSpring Health Services	N/A	N/A	N/A	N/A	N/A
OPCH Option Care Health	N/A	N/A	N/A	N/A	N/A
RDNT RadNet	N/A	N/A	N/A	N/A	N/A
VRDN Viridian Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTSG BrightSpring Health Services	1.48	1.73	1.37
OPCH Option Care Health	0.82	1.54	1.02
RDNT RadNet	0.87	2.01	2.01
VRDN Viridian Therapeutics	0.05	19.49	19.49

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BTSG BrightSpring Health Services	N/A
OPCH Option Care Health	98.05%
RDNT RadNet	77.90%
VRDN Viridian Therapeutics	N/A

Insider Ownership

Company	Insider Ownership
BTSG BrightSpring Health Services	3.40%
OPCH Option Care Health	0.64%
RDNT RadNet	5.60%
VRDN Viridian Therapeutics	0.65%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BTSG BrightSpring Health Services	35,000	175.80 million	169.83 million	Optionable
OPCH Option Care Health	8,088	163.75 million	162.70 million	Optionable
RDNT RadNet	11,021	75.03 million	70.83 million	Optionable
VRDN Viridian Therapeutics	50	81.59 million	81.06 million	Optionable

VRDN, OPCH, RDNT, and BTSG Headlines

Recent News About These Companies

Principal Financial Group Inc. Acquires 30,392 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)

July 19 at 3:33 AM | marketbeat.com

Viridian Therapeutics’ Veligrotug Shows Durable Proptosis Response in Phase 3 TED Trial

July 15, 2025 | msn.com

Rice Hall James & Associates LLC Acquires 309,518 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)

July 14, 2025 | marketbeat.com

Viridian Therapeutics price target lowered to $38 from $41 at Evercore ISI

July 11, 2025 | msn.com

Viridian Therapeutics Sees Relative Strength Rating Improve To 79

July 10, 2025 | msn.com

Viridian Therapeutics (NASDAQ:VRDN) Trading Up 8.4% - Here's Why

July 9, 2025 | marketbeat.com

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Rating of "Moderate Buy" from Analysts

July 7, 2025 | marketbeat.com

Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 3, 2025 | finance.yahoo.com

Viridian Therapeutics’ SWOT analysis: promising TED treatment stock faces pivotal year

June 15, 2025 | investing.com

Viridian Therapeutics: The Song Remains The Same

June 9, 2025 | seekingalpha.com

Viridian Therapeutics to Participate in Upcoming June Investor Conferences

May 30, 2025 | businesswire.com

Veligrotug improves proptosis, diplopia symptoms in active, chronic thyroid eye disease

May 22, 2025 | healio.comH

Viridian Therapeutics’ SWOT analysis: promising TED treatment stock faces key catalysts

May 21, 2025 | investing.com

Viridian Therapeutics announces positive long-term durability data for veligrotug for the treatment of active thyroid eye disease

May 20, 2025 | ophthalmologytimes.comO

Why Viridian Therapeutics, Inc.’s (VRDN) Stock Is Down 5.15%

May 15, 2025 | aaii.comA

Veligrotug receives breakthrough therapy designation for thyroid eye disease

May 9, 2025 | healio.comH

Viridian Therapeutics Receives FDA Breakthrough Therapy Designation for Veligrotug for the Treatment of Thyroid Eye Disease (TED)

May 7, 2025 | finance.yahoo.com

Viridian Therapeutics shares fall as Q1 loss narrows, revenue beats

May 6, 2025 | in.investing.com

Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2025 Financial Results

May 6, 2025 | finance.yahoo.com

Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Lags Revenue Estimates

May 6, 2025 | zacks.com

Why Viridian Therapeutics, Inc.’s (VRDN) Stock Is Up 5.71%

April 16, 2025 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

VRDN, OPCH, RDNT, and BTSG Company Descriptions

BrightSpring Health Services NASDAQ:BTSG

$19.94 -0.16 (-0.80%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$20.08 +0.13 (+0.68%)

As of 07/18/2025 04:23 PM Eastern

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Option Care Health NASDAQ:OPCH

$29.48 -0.46 (-1.54%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$29.74 +0.26 (+0.88%)

As of 07/18/2025 07:19 PM Eastern

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

RadNet NASDAQ:RDNT

$57.49 -1.35 (-2.29%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$57.48 -0.01 (-0.01%)

As of 07/18/2025 07:20 PM Eastern

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Viridian Therapeutics NASDAQ:VRDN

$16.52 -0.53 (-3.11%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$16.52 0.00 (0.00%)

As of 07/18/2025 05:45 PM Eastern

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time